ResearchIn-Press PreviewImmunology
Open Access | 10.1172/jci.insight.185548
1Medicine, Washington University School of Medicine, St. Louis, United States of America
2Department of Molecular Diagnostics and Endocrinology, Shanghai Jiaotong University School of Medicine, Shanghai, China
3Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, United States of America
Find articles by Ren, Z. in: JCI | PubMed | Google Scholar
1Medicine, Washington University School of Medicine, St. Louis, United States of America
2Department of Molecular Diagnostics and Endocrinology, Shanghai Jiaotong University School of Medicine, Shanghai, China
3Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, United States of America
Find articles by Bao, J. in: JCI | PubMed | Google Scholar
1Medicine, Washington University School of Medicine, St. Louis, United States of America
2Department of Molecular Diagnostics and Endocrinology, Shanghai Jiaotong University School of Medicine, Shanghai, China
3Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, United States of America
Find articles by
Zhao, S.
in:
JCI
|
PubMed
|
Google Scholar
|
1Medicine, Washington University School of Medicine, St. Louis, United States of America
2Department of Molecular Diagnostics and Endocrinology, Shanghai Jiaotong University School of Medicine, Shanghai, China
3Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, United States of America
Find articles by
Pozzi, N.
in:
JCI
|
PubMed
|
Google Scholar
|
1Medicine, Washington University School of Medicine, St. Louis, United States of America
2Department of Molecular Diagnostics and Endocrinology, Shanghai Jiaotong University School of Medicine, Shanghai, China
3Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, United States of America
Find articles by Wedner, H. in: JCI | PubMed | Google Scholar
1Medicine, Washington University School of Medicine, St. Louis, United States of America
2Department of Molecular Diagnostics and Endocrinology, Shanghai Jiaotong University School of Medicine, Shanghai, China
3Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, United States of America
Find articles by Atkinson, J. in: JCI | PubMed | Google Scholar
Published January 17, 2025 - More info
Hereditary angioedema is an autosomal dominant disorder caused by defects in C1-esterase inhibitor (C1-INH), resulting in poorly controlled activation of the kallikrein-kinin system and bradykinin overproduction. C1-INH is a heavily glycosylated protein in the serine protease inhibitor (SERPIN) family, yet the role of these glycosylation sites remains unclear. To elucidate the functional impact of N-glycosylation in the SERPIN domain of C1-INH, we engineered four sets consisting of 26 variants at or near the N-linked sequon (NXS/T). Among these, six are reported in HAE patients and five are known C1-INH variants without accessible clinical histories. We systematically evaluated their expression, structure and functional activity with C1¯s, FXIIa and kallikrein. Our findings showed that of the eleven reported variants, seven are deleterious. Deleting N at the three naturally occurring N-linked sequons (N238, N253 and N352) results in pathologic consequences. Altering these sites by substituting N to A disrupts N-linked sugar attachment but preserves protein expression or function. Further, an additional N-linked sugar generated at N272 impairs C1-INH function. These findings highlight the importance of N-linked sequons in modulating the expression and function of C1-INH. Insights gained from identifying the pathological consequences of N-glycan variants should assist in defining more tailored therapy.